Skip to main content
Molecular Medicine logoLink to Molecular Medicine
. 2025 Jun 4;31:220. doi: 10.1186/s10020-025-01276-5

Correction: SNORA47 affects stemness and chemotherapy sensitivity via EBF3/RPL11/c-Myc axis in luminal A breast cancer

Qilin Han 1,2, Ying Zhou 1, Zixian Dong 1, Weitao Wang 3, Menghan Wang 1, Mengyang Pang 1, Xinyue Song 3, Bo Chen 1, Ang Zheng 1,✉
PMCID: PMC12135521  PMID: 40468195

Correction: Mole Med 31, 150 (2025)

https://doi.org/10.1186/s10020-025-01216-3

In this article (Han et al. 2025), Fig. 2 appeared incorrectly and have now been corrected in the original publication. For completeness and transparency, both correct and incorrect versions are displayed below.

The original article has been corrected.

Incorrect Figure 2

graphic file with name 10020_2025_1276_Figa_HTML.jpg

Correct Figure 2

graphic file with name 10020_2025_1276_Figb_HTML.jpg

References

  1. Han, Q., Zhou, Y., Dong, Z. et al. SNORA47 affects stemness and chemotherapy sensitivity via EBF3/RPL11/c-Myc axis in luminal A breast cancer. Mol Med 31, 150 (2025). 10.1186/s10020-025-01216-3. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Molecular Medicine are provided here courtesy of The Feinstein Institute for Medical Research at North Shore LIJ

RESOURCES